Risk Of Incorrect Content: Concept Clearance » Autism Biomarkers for Clinical Trials

The article below may contain offensive and/or incorrect content.

The goal of this initiative is to encourage the necessary next stages of development and validation of biomarkers with putative value for use in clinical trials for treatments of the core social deficits of Autism Spectrum Disorder (ASD), including multi-site testing and validation for a specific 'context of use' (e.g., diagnostic, enrichment, stratification) as a drug development tool.